2023
Hemolytic disease of the fetus and newborn mediated by anti-Dia in a U.S. hospital
Jacobs J, Abels E, Binns T, Tormey C, Sostin N. Hemolytic disease of the fetus and newborn mediated by anti-Dia in a U.S. hospital. Immunohematology 2023, 39: 32-34. PMID: 37017601, DOI: 10.21307/immunohematology-2023-006.Peer-Reviewed Case Reports and Technical NotesConceptsHemolytic diseaseCases of HDFNU.S. hospitalsHemolytic transfusion reactionsDirect antiglobulin testNeonatal bilirubin levelsSouth American descentAntibody detection testsLow-prevalence antigensU.S. patient populationNear universal absenceHDFN casesBilirubin levelsPatient populationTransfusion reactionsAntiglobulin testUnexpected causeHispanic ethnicityBlood group systemAntigenAntibodiesHDFNHospitalFetusesDisease
2022
Incidental Discovery of a Patient with the Bombay Phenotype
Jacobs JW, Horstman E, Gisriel SD, Tormey CA, Sostin N. Incidental Discovery of a Patient with the Bombay Phenotype. Lab Medicine 2022, 54: e14-e17. PMID: 35776424, DOI: 10.1093/labmed/lmac075.Peer-Reviewed Case Reports and Technical NotesConceptsRed blood cellsH antigensIncidental discoveryAcute hemolytic transfusion reactionBombay phenotypeHemolytic transfusion reactionsAmerican hospital systemRare blood typesTransfusion reactionsCompatible bloodB antigensBlood typeAntigenBlood cellsHospital systemABO phenotypingBlood phenotypeABO systemPatientsPara-Bombay phenotypeType OH deficiencyPhenotypeIll effectsIndividuals